Michael A. Thompson, MD, PhD, medical director, precision medicine, Vince Lombardi Cancer Clinic, Aurora Health Care, discusses the future of treatment in multiple myeloma.
Immunotherapy may be beneficial in patients with later stages of multiple myeloma, says Thompson. Combinations with checkpoint inhibitors are currently being explored.
For patients with early disease that have a high risk of progressing from smoldering myeloma to myeloma, a combination of induction, consolidation, and maintenance may be curative, adds Thompson. –
LINK TO VIDEO